References
Cseuz R, Panayi GS. The inhibition of NK cell function by azathioprine during the treatment of patients with rheumatoid arthritis. Br J Rheumatol. 1990;29(5):358–62.
Salmaggi A, Corsini E, La Mantia L, Dufour A, Eoli M, Milanese C, et al. Immunological monitoring of azathioprine treatment in multiple sclerosis patients. J Neurol. 1997;244(3):167–74.
Shearer WT, Rosenblatt HM, Gelman RS, Oyomopito R, Plaeger S, Stiehm ER, et al. Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study. J Allergy Clin Immunol. 2003;112(5):973–80.
McCarthy NE, Hedin CR, Sanders TJ, Amon P, Hoti I, Ayada I, et al. Azathioprine therapy selectively ablates human Vdelta2(+) T cells in Crohn's disease. J Clin Invest. 2015;125(8):3215–25.
Fehniger TA, Caligiuri MA. Interleukin 15: biology and relevance to human disease. Blood. 2001;97(1):14–32.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Conflict of Interest Statement
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Orandi, A.B., Vogel, T.P., Keppel, M.P. et al. Azathioprine-Associated Complete NK Cell Deficiency. J Clin Immunol 37, 514–516 (2017). https://doi.org/10.1007/s10875-017-0414-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10875-017-0414-6